Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
Clinical trial NCT00895180 · COMPLETED
Trial details
- NCT number
- NCT00895180
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-06-22
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.